EGFR tyrosine kinase inhibitors (class)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR tyrosine kinase inhibitors (class), covering 2013-12-12 to 2013-12-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC